Gene Therapy Described in a Patient With Sickle Cell Disease

Share this content:
Gene Therapy Described in a Patient With Sickle Cell Disease
Gene Therapy Described in a Patient With Sickle Cell Disease

THURSDAY, March 2, 2017 (HealthDay News) -- In a brief report published in the March 2 issue of the New England Journal of Medicine, researchers detail their early success using gene therapy to treat, or even potentially cure, sickle cell disease.

A team, led by Marina Cavazzana, M.D., Ph.D., of the Necker Hospital for Sick Children in Paris, focused on beta globin. First, the researchers extracted a stem cell supply from their adolescent patient's bone marrow, before using chemotherapy to wipe out the remaining stem cells. Then they used a modified virus to deliver an "anti-sickling" version of the beta globin gene into the stem cells they'd removed before chemotherapy. The modified stem cells were infused back into the patient.

Over the next few months, the male patient showed a growing number of new blood cells bearing the mark of the anti-sickling gene. The result was that roughly half of his hemoglobin was no longer abnormal.

"Longer follow-up is required to confirm the durability of the efficacy and safety profile observed, and data from additional evaluations of gene therapy in a larger cohort of patients to confirm the promise of gene therapy for sickle cell disease are lacking," the authors write.

The study was partly funded by Bluebird Bio, the company developing the therapy.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

NAFLD Linked to Smaller Total Cerebral Brain Volume

NAFLD Linked to Smaller Total Cerebral Brain Volume

Significant correlation even after adjustment for all covariates, including age, sex, alcohol consumption

Salivary miRNAs Can ID Duration of Concussion Symptoms

Salivary miRNAs Can ID Duration of Concussion Symptoms

Pediatric patients with prolonged symptoms were accurately identified by levels of five miRNAs

Treatment Trajectories Vary for Children With Depression

Treatment Trajectories Vary for Children With Depression

Most common class got psychotherapy monotherapy, and had lowest incidence of attempted suicide

is free, fast, and customized just for you!

Already a member?

Sign In Now »